C3orf52 (TTMP) was described as a tumor suppressor in pancreatic adenocarcinoma cell line28; in our study, it was downregulated in tumor tissue and correlated with stage and overall survival of ccRCC patients. Here, C3orf52 is linked to nonpapillary renal cell carcinoma.